EP2950664A1 - Verfahren zur herstellung eines nahrungsmittels sowie das damit hergestellte nahrungsmittel und verwendung von milchsäurebakterien, eines sauerguts, einer maische, einer würze, eines getränks oder eines konzentrats - Google Patents
Verfahren zur herstellung eines nahrungsmittels sowie das damit hergestellte nahrungsmittel und verwendung von milchsäurebakterien, eines sauerguts, einer maische, einer würze, eines getränks oder eines konzentratsInfo
- Publication number
- EP2950664A1 EP2950664A1 EP14702518.3A EP14702518A EP2950664A1 EP 2950664 A1 EP2950664 A1 EP 2950664A1 EP 14702518 A EP14702518 A EP 14702518A EP 2950664 A1 EP2950664 A1 EP 2950664A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- food
- wort
- mash
- vitamin
- concentrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 151
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 75
- 239000004310 lactic acid Substances 0.000 title claims abstract description 75
- 239000012141 concentrate Substances 0.000 title claims abstract description 73
- 241000894006 Bacteria Species 0.000 title claims abstract description 65
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 40
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 title claims abstract description 30
- 239000002253 acid Substances 0.000 title claims abstract description 22
- 235000015097 nutrients Nutrition 0.000 claims abstract description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000000203 mixture Substances 0.000 claims abstract description 29
- 239000002243 precursor Substances 0.000 claims abstract description 11
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 122
- 238000000034 method Methods 0.000 claims description 101
- 235000013305 food Nutrition 0.000 claims description 98
- 235000013405 beer Nutrition 0.000 claims description 58
- 239000002609 medium Substances 0.000 claims description 51
- 235000013361 beverage Nutrition 0.000 claims description 41
- 230000008569 process Effects 0.000 claims description 35
- 241000894007 species Species 0.000 claims description 35
- 235000013339 cereals Nutrition 0.000 claims description 31
- 241001465754 Metazoa Species 0.000 claims description 16
- 235000011194 food seasoning agent Nutrition 0.000 claims description 15
- 241000209140 Triticum Species 0.000 claims description 11
- 235000021307 Triticum Nutrition 0.000 claims description 11
- 239000004615 ingredient Substances 0.000 claims description 9
- 235000007672 methylcobalamin Nutrition 0.000 claims description 9
- 239000011585 methylcobalamin Substances 0.000 claims description 9
- JEWJRMKHSMTXPP-BYFNXCQMSA-M methylcobalamin Chemical compound C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O JEWJRMKHSMTXPP-BYFNXCQMSA-M 0.000 claims description 9
- 235000015173 baked goods and baking mixes Nutrition 0.000 claims description 8
- 235000015496 breakfast cereal Nutrition 0.000 claims description 8
- 229910001415 sodium ion Inorganic materials 0.000 claims description 8
- 235000013618 yogurt Nutrition 0.000 claims description 8
- OAJLVMGLJZXSGX-CXGXMSGESA-L (2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(4z,9z,14z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8 Chemical compound [Co+3].O[C@@H]1[C@H](O)[C@@H]([CH2-])O[C@H]1N1C2=NC=NC(N)=C2N=C1.O([C@H]1[C@H]([C@H](O[C@@H]1CO)N1C2=CC(C)=C(C)C=C2N=C1)O)P([O-])(=O)OC(C)CNC(=O)CCC1(C)C(CC(N)=O)C2[N-]\C1=C(C)/C(C(C\1(C)C)CCC(N)=O)=N/C/1=C\C(C(C/1(CC(N)=O)C)CCC(N)=O)=N\C\1=C(C)/C1=NC2(C)C(C)(CC(N)=O)C1CCC(N)=O OAJLVMGLJZXSGX-CXGXMSGESA-L 0.000 claims description 7
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 7
- 229920002498 Beta-glucan Polymers 0.000 claims description 7
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 7
- YOZNUFWCRFCGIH-BYFNXCQMSA-L hydroxocobalamin Chemical compound O[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O YOZNUFWCRFCGIH-BYFNXCQMSA-L 0.000 claims description 6
- 229930091371 Fructose Natural products 0.000 claims description 5
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 5
- 239000005715 Fructose Substances 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 241000186660 Lactobacillus Species 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 239000006872 mrs medium Substances 0.000 claims description 5
- 235000013365 dairy product Nutrition 0.000 claims description 4
- 235000013336 milk Nutrition 0.000 claims description 4
- 239000008267 milk Substances 0.000 claims description 4
- 210000004080 milk Anatomy 0.000 claims description 4
- 235000004867 hydroxocobalamin Nutrition 0.000 claims description 3
- 239000011704 hydroxocobalamin Substances 0.000 claims description 3
- 229960001103 hydroxocobalamin Drugs 0.000 claims description 3
- 239000002535 acidifier Substances 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 240000005979 Hordeum vulgare Species 0.000 claims 1
- 241000186842 Lactobacillus coryniformis Species 0.000 abstract description 17
- 241000159904 Lactobacillus backii Species 0.000 abstract description 7
- 235000006085 Vigna mungo var mungo Nutrition 0.000 description 64
- 240000005616 Vigna mungo var. mungo Species 0.000 description 64
- 235000008504 concentrate Nutrition 0.000 description 60
- 239000000047 product Substances 0.000 description 48
- 230000020477 pH reduction Effects 0.000 description 22
- 230000001476 alcoholic effect Effects 0.000 description 21
- 239000008234 soft water Substances 0.000 description 18
- 235000020017 wheat beer Nutrition 0.000 description 18
- 230000008901 benefit Effects 0.000 description 17
- 239000002054 inoculum Substances 0.000 description 16
- 241000202368 Lactobacillus coryniformis subsp. coryniformis Species 0.000 description 13
- 239000000758 substrate Substances 0.000 description 13
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 12
- 241000186713 Lactobacillus amylovorus Species 0.000 description 12
- 239000011230 binding agent Substances 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 9
- 244000005700 microbiome Species 0.000 description 9
- 229930003231 vitamin Natural products 0.000 description 9
- 235000013343 vitamin Nutrition 0.000 description 9
- 239000011782 vitamin Substances 0.000 description 9
- 229940088594 vitamin Drugs 0.000 description 9
- 150000003722 vitamin derivatives Chemical class 0.000 description 9
- 150000001720 carbohydrates Chemical class 0.000 description 8
- 235000014633 carbohydrates Nutrition 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000011081 inoculation Methods 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 241000209219 Hordeum Species 0.000 description 6
- 229930003270 Vitamin B Natural products 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 6
- 230000002906 microbiologic effect Effects 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 239000008188 pellet Substances 0.000 description 6
- 235000019156 vitamin B Nutrition 0.000 description 6
- 239000011720 vitamin B Substances 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 5
- 230000001766 physiological effect Effects 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 239000002028 Biomass Substances 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 241001647783 Lactobacillus amylolyticus Species 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
- 238000012474 bioautography Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 235000014214 soft drink Nutrition 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 241000186429 Propionibacterium Species 0.000 description 3
- 241000186428 Propionibacterium freudenreichii Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 3
- 235000000639 cyanocobalamin Nutrition 0.000 description 3
- 239000011666 cyanocobalamin Substances 0.000 description 3
- 229960002104 cyanocobalamin Drugs 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000000265 homogenisation Methods 0.000 description 3
- 238000004811 liquid chromatography Methods 0.000 description 3
- 238000004890 malting Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 2
- 239000004278 EU approved seasoning Substances 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241000186604 Lactobacillus reuteri Species 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 241000186334 Propionibacterium freudenreichii subsp. shermanii Species 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940010007 cobalamins Drugs 0.000 description 2
- 150000001867 cobalamins Chemical class 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000011868 grain product Nutrition 0.000 description 2
- 235000014168 granola/muesli bars Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- DQOCFCZRZOAIBN-WZHZPDAFSA-L hydroxycobalamin Chemical compound O.[Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O DQOCFCZRZOAIBN-WZHZPDAFSA-L 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 235000021577 malt beverage Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 229940045999 vitamin b 12 Drugs 0.000 description 2
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-M (R)-lactate Chemical compound C[C@@H](O)C([O-])=O JVTAAEKCZFNVCJ-UWTATZPHSA-M 0.000 description 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-M (S)-lactate Chemical compound C[C@H](O)C([O-])=O JVTAAEKCZFNVCJ-REOHCLBHSA-M 0.000 description 1
- QOIRFXTZHVPXLR-UHFFFAOYSA-N 2,3,5-triphenyl-1h-tetrazole Chemical class N1N(C=2C=CC=CC=2)N(C=2C=CC=CC=2)N=C1C1=CC=CC=C1 QOIRFXTZHVPXLR-UHFFFAOYSA-N 0.000 description 1
- -1 7-adeninyl Chemical group 0.000 description 1
- 235000020020 Berliner weiße Nutrition 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 241001138401 Kluyveromyces lactis Species 0.000 description 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- VAYOSLLFUXYJDT-RDTXWAMCSA-N Lysergic acid diethylamide Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N(CC)CC)C2)=C3C2=CNC3=C1 VAYOSLLFUXYJDT-RDTXWAMCSA-N 0.000 description 1
- 244000018764 Nyssa sylvatica Species 0.000 description 1
- 235000003339 Nyssa sylvatica Nutrition 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 241000222126 [Candida] glabrata Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000013124 brewing process Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 235000012182 cereal bars Nutrition 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical group [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940116871 l-lactate Drugs 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 235000020022 lambic Nutrition 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000020429 malt syrup Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003923 mental ability Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000037074 physically active Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 235000021108 sauerkraut Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1315—Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/117—Flakes or other shapes of ready-to-eat type; Semi-finished or partly-finished products therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/20—Malt products
- A23L7/25—Fermentation of cereal malt or of cereal by malting
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C11/00—Fermentation processes for beer
- C12C11/06—Acidifying the wort
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C12/00—Processes specially adapted for making special kinds of beer
- C12C12/002—Processes specially adapted for making special kinds of beer using special microorganisms
- C12C12/008—Lactic acid bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C12/00—Processes specially adapted for making special kinds of beer
- C12C12/04—Beer with low alcohol content
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C7/00—Preparation of wort
- C12C7/24—Clarifying beerwort between hop boiling and cooling
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a process for producing an acidification product, an acidification product, a process for producing a mash or a wort, a mash and / or wort, a process for the preparation of a beverage, a beverage, a process for the preparation of a concentrate, a concentrate , a process for producing a food, a food, the use of lactic acid bacteria, the use of an acid, a mash, a wort or a concentrate, a process for producing a malt, and a process for producing a soft water.
- Vitamin Bi 2 plays an important role in cell division, blood formation, nervous system function, mental abilities and the metabolism of carbohydrates, fats and proteins. In the case of a deficiency of vitamin B 2 , therefore, significant metabolic disorders or other physical impairments may occur.
- Vitamin Bi 2 is a collective term for a number of water-soluble, structurally similar compounds with biological activity, the so-called corrinoids. Due to the complexed cobalt atom, they are referred to as cobalamins.
- cobalamins Due to the complexed cobalt atom, they are referred to as cobalamins.
- To the biocompatible vitamin Bi2 forms are those skilled in the art: methylcobalamin, deoxyadenosylcobalamin, hydroxycobalamin and sulfitcobalamin. Of these, methylcobalamin and deoxyadenosylcobalamin are considered to be the most biologically active forms.
- cyanocobalamin is only artificial, i. accessible by synthetic means.
- inactive analogues In addition to these active forms of vitamin Bi2, there are also so-called inactive analogues. These are also called pseudo-vitamin Bi 2 because, although they have a similar chemical structure as the real vitamin Bi 2 , but may develop no vitamin effect on the human or animal body. They are not suitable to fulfill physiological tasks of the vitamin Bi 2 in the organism. Furthermore, they can block the uptake and metabolism of biologically active vitamin Bi2.
- pseudo-vitamin Bi 2 is understood as meaning, in particular, 7-adeninyl cyanocobamide.
- the definition of the term “Vitamin Bi 2 " is restricted to the forms of the vitamin Bi 2 or their precursors active in the human or animal organism.Furthermore, the term “Vitamin Bi 2 " in the context of this application refers to forms of the vitamin Bi 2 limited, which can be produced microbiologically. Since the above-mentioned cyanocobalamin can only be produced synthetically and therefore does not constitute a "natural" vitamin Bi 2 , this form of vitamin Bi 2 is not covered by the term “vitamin Bi 2 " in the context of this application.
- vitamin Bi 2 in the context of this application is limited to the following vitamin Bi 2 species: methylcobalamin, deoxyadenosylcobalamin, hydroxycobalamin and sulfitcobalamin.
- bioavailability is defined as the absorption of the nutrient (vitamin B 2) understood from the gastrointestinal tract into the blood, causing it reaches the systemic circulation and thus available to the cells / organs available.
- bioavailable or “bioavailability” is referred to paragraph [0013] of the specification of International Patent Publication WO 2012/109 324 AI, the content of which is hereby incorporated by reference.
- the bioavailability of vitamin Bi 2 can be determined by the so-called radio immunoassay / chemiluminescence test according to Geissei or by the method of Watanabe's bioautography.
- bioavailable in connection with vitamin Bi 2 is understood as meaning the substance or those substances which are detected as bioavailable by means of the measuring method developed by Tanioka, Watanabe et al., In which the vitamin Bi 2 The mixture is then concentrated by means of silica gel TLC and incubated with the vitamin Bi 2 -dependent E. coli strain 215, before the samples are then visualized by 2,3,5-triphenyltetrazolium salt Tanioka Y.
- the term "sour” is understood to mean the customary definition familiar in the field of brewing technology, which is understood to mean in particular a nutrient medium, in particular a mash and / or wort, treated microbially to reduce the pH, preferably with lactic acid bacteria.
- the terms “mash” and “wort” are to be understood in particular as meaning the substrates which the person skilled in the art knows from the beer preparation process under the same name.
- the terms are not necessarily limited thereto, but may also refer to analogous substrates, ie precursors, with regard to other beverages or other foods, such as whiskey mashes.
- the term "mash” may preferably be restricted to a mash which has been produced using a carbohydrate-containing substrate or a mixture of carbohydrate-containing substrates, in which case the carbohydrate-containing substrate or the mixture of carbohydrate-containing substrates has a brewing-stone content of at least 80% by mass.
- the term "mash” may in particular be restricted to a mash which was prepared using brewing salt, the brewing salt having a content of wheat malt of at least 50% by mass, preferably at least 52% by mass, in particular at least 55% by mass.
- the term "brewing salt” includes malt of one kind and also mixtures of different types of malt.
- the term "wort” can be restricted to a wort which has been obtained from a mash which is made using brewing salt with a proportion of wheat malt of at least 50% by mass, preferably at least 52% by mass, in particular at least 55% by mass. %, was produced.
- treatment means any type of partial or complete metabolisation of nutrients originating from a nutrient medium, in particular a partial or complete fermentation by lactic acid bacteria.
- “treating” may be any mode of contacting microorganisms, preferably lactic acid bacteria, in particular with the lactic acid bacteria provided for in this application with a nutrient medium
- lactic acid bacteria for the purposes of this application encompasses any type and condition of lactic acid bacteria, i. any kind or subspecies or any strain, as far as this is not further limited in this application.
- this term encompasses living and / or dead bacterial cells, in particular living bacterial cells.
- wheat beer is understood to mean a top-fermented beer having a wheat-malt content of at least 50% by mass, preferably at least 52% by mass, in particular at least 55% by mass, in the bed or in the carbohydrate-containing substrate.
- the terms "food”, “beverage”, “beer” and “wheat beer” according to the invention may be limited in such a way that they do not contain beers of the varieties “Berlinerppe”, “Lambic”, “Gueze”, “Duvel” and / or Include “Belgian Whitbier”.
- non-alcoholic in relation to a food, beverage or beer or any other claimed in this application product according to the invention a content of ethanol in the product of 0 to less than 1.2% by volume, preferably from 0 to less than 1.0% by volume, preferably from 0 to less than 0.5% by volume), preferably from 0 to less than 0.3% by volume, preferably from 0 to less than 0.1% by volume, in particular about 0% by volume.
- the term "about”, “about” or the like is understood to mean a relative deviation from the respective reference value of at most 10%, preferably at most 5%, preferably at most 3%, in particular at most 1%.
- volume or volume fractions used in this application always refer to the temperature or temperatures which a person skilled in the art typically would associate with the fluid or mixture related thereto for the particular use or process step, unless a temperature is explicitly stated.
- the document EP 0 545 139 Bl discloses a malt beverage which has an unfermented malt syrup with a wort content of between 2 and 15%. This malt beverage may be slightly hopped and has a cyanocobalamin content in the range of 5 to 30 micrograms per liter.
- the document EP 824 152 Bl describes the production of natural vitamin Bi 2 in relatively high concentrations (> 0.1% by weight) using Propionibacterium freudenreichii.
- GB 793 467 A relates to the production of preparations having a high vitamin B 2 - in particular exhibit activity by cultivation of a particular type of Propionibacterium, in particular P. freudenheimii shermanii or P..
- a method for producing a physiological active preparation of vitamin Bi 2 which is free of pseudo or inactive vitamin Bi 2 variants.
- the document US 6 492 141 Bl deals with the industrial production of vitamin Bi 2 using Propionibacterium.
- the document US 2006/0 051 323 Al discloses a foodstuff which
- Particles comprising a microbial biomass and a solid support, wherein the biomass contains vitamin Bi 2 .
- the biomass may include, for example, Propionibacterium, preferably P. freudenreichii.
- the biomass thus produced can be used as a food additive.
- the document WO 2012/143 469 AI discloses a food product in bar form containing solid particles, for example consisting of cereal grains, as well as vitamin Bi 2 in the form of various cobalamins.
- the document WO 2009/124 529 A2 discloses a process for producing a soft drink obtained with microbiologically formed cobalamin by the additional inoculation with a cobalamin synthesizing microorganism strain.
- cobalamin-synthesizing microorganism species such as Torulopsis glabrata, Lactobacillus lactis (lactis), Kluyveromyces lactis, Yarrowina lipolytica, Hansenula glucocyma, Saccharomyces italicus, Lactobacillus reuterii, Lactobacillus fermentum and / or Lactobacillus casei.
- the object of the present invention is to provide an acid, a mash, a wort, a beverage, a concentrate, a food, a malt and / or a soft water, and the corresponding production processes and uses for these products, which products are suitable Vitamin B 12 - to improve the supply of the human and / or animal body when these products or foods derived therefrom are consumed. It is an aspect of the present invention, foods or theirs
- the properties preferably taste and smell, taste stability, physical stability or turbidity stability, foam stability and / or the biological or microbiological durability understood.
- A providing a first nutrient medium, preferably a nutrient broth, in particular an MRS medium, a mash and / or a wort, in particular a wort, or a smooth water; and
- Lactic acid bacteria is obtained an acidity containing vitamin Bi 2 , which is essentially completely or at least to a high proportion bio available, in particular for the human and / or animal body bio available or human bioavailable.
- the Applicant has surprisingly found that the lactic acid bacteria used according to the invention produce vitamin Bi 2 in such a medium and thus produce vitamin Bi 2 are suitable. Furthermore, it was surprisingly found that the vitamin Bi 2 produced by means of the lactic acid bacteria used according to the invention is also bioavailable in the meaning of this application.
- the preferred nutrient media in particular a mash or wort, mentioned in point 1 above, are used as the first nutrient medium, it is advantageously achieved that, when the lactic acid bacteria provided according to the invention are used in the treatment step, the vitamin Bi 2 produced is substantially completely or at least to a high proportion of bio is available. According to the invention an active generation of bio available vitamin Bi 2 reaches may when using the method according to the invention therefore be readily apparent that a "switching" the metabolism of the inventively provided lactic acid bacteria occurs on the production of non-bioavailable vitamin Bi. 2 Such a switching is, for example, of lactic acid bacteria of other species, such as Lactobacillus reuterii.
- the wort in step (a) has an extract content in the range of 8 to 28%, preferably 10 to 22%, in particular 12 to 19%, in particular 14 to 16%.
- Wort wort as a nutrient medium is characterized by a high content of nutrients required for the lactic acid bacteria used in the process according to the invention.
- wort is readily available and easy to produce with the facilities of a conventional brewery.
- the inventive method is also in highly concentrated culture media, which are obtained for example in the high-gravity process, while achieving the associated advantages, in particular volume and cost savings, applicable.
- step (c) after step (a) and before step (b), diluting the first nutrient medium with water, in particular brewing water, such that the extract content of the resulting Dilution in the range of 5 to 10%, preferably 6 to 9%, in particular 7 to 8%.
- step (b) the first nutrient medium is inoculated with the lactic acid bacteria in an amount that the optical density (OD) of the first nutrient medium immediately after inoculation in the field from about 0.1 to 1.0 OD, preferably 0.2 to 0.8, preferably 0.3 to 0.7, preferably 0.4 to 0.5 OD, in particular about 0.45 OD, wherein the measured value of the optical density is measured at a wavelength of 620 nm and adjusted for the influence of the first nutrient medium. Inoculation of the first nutrient medium with the invention used
- Microorganisms such that the above-mentioned optical density (OD) or a corresponding cell density is set at the beginning of the treatment leads to a rapid reaction and thus to an advantageous short treatment time.
- an optimal inoculum concentration of the lactic acid bacteria results in an optimal flavor profile with minimal levels of off-flavors or their complete absence.
- step (d) after step (b), enriching, preferably by partial or substantially complete or complete centrifuging, the lactic acid bacteria contained in the sourgut;
- step (e) partially or substantially completely or completely separating the liquid phase or supernatant resulting from step (d).
- lactic acid bacteria enriched acidity is depleted in lactate, which can effectively prevent acidification when using the enriched sourdough.
- lactate lactate
- the present invention is not limited to concentrating by centrifugation.
- each one can One skilled in the art and suitable enrichment, concentration or separation, such as filtration, sedimentation or thermal processes are used.
- 6. The method according to at least one of the preceding numbers 1 to 5, characterized in that the lactic acid bacteria are in their addition to the first nutrient medium according to step (b) in the log phase or growth phase.
- Inoculation with microorganisms which are in the log phase (logarithmic phase) or growth phase, advantageously leads to a rapid conversion of the first nutrient medium to the sourgut due to the high activity of the microorganisms used.
- the treatment period provided according to the invention can advantageously be limited to the short periods of time specified above. As a result, a short-term provision of a sour good can be realized. In particular, at a treatment time of less than 5 hours, the yield of vitamin Bi 2 and / or lactate is too low. In contrast, no further increase in the production of bioavailable vitamin Bi 2 is achieved with a treatment duration of more than 50 hours. There is also the danger of hyperacidity.
- step (b) at a temperature of the nutrient medium in the range of about 15 to 48 ° C, preferably 25 to 42 ° C, in particular 32 to 40 ° C, in particular 35 to 39 ° C, in particular 36 to 38 ° C, is performed.
- the treatment according to step (b) can advantageously take place in a wide temperature range. Selecting the temperature between about 30 and 40 ° C provides optimal growth conditions for the microorganisms used, thereby shortening the required treatment time and obtaining optimum quality of the resulting product.
- step (e) after step (b), sterilizing the nutrient medium treated according to step (b).
- the lactic acid bacteria used in the invention may have an undesirable influence on the respective product in the further use of the acid, for example in the context of a food or beverage production, especially in beer production.
- Sterilization can thus take place with all means known to those skilled in the art. Preference is given to the addition of acidification to the boiling or hot wort.
- step (f) Ensuring the microbiological stability of the sourgut according to the invention. 11.
- the method according to number 10 characterized in that in step (f), the mass fraction of water in the sourgut to more than 0%, preferably more than 5%, is set. By setting a residual water content in the sourgut, dust formation during processing or handling of the sourgut is avoided.
- the choice of anaerobic conditions or substantially anaerobic conditions during the treatment of the nutrient medium with the lactic acid bacteria used according to the invention has a positive effect on the quantity and / or bioavailability of the vitamin Bi 2 produced .
- Anaerobic conditions are preferably prepared by air termination and / or gassing with C0 2 or N 2 or other known measures.
- the sourgut contains vitamin Bi 2 ,
- vitamin Bi 2 contained in the sourgut a mass fraction of at least 80%, preferably at least 90%, preferably at least 95%, preferably at least 98%, preferably at least 99%, in particular 100%, bioavailable, in particular bioavailable to the human or animal body.
- the vitamin Bi 2 contained in the sourgut according to the invention is completely or at least substantially bio available.
- the high bioavailability of the vitamin Bi 2 in the acidified product according to the invention means that the acidified product claimed according to the invention is suitable for improving the vitamin B 2 supply of humans and / or an animal.
- the representatives of the aforementioned group are characterized by a high bioavailability, so that they are suitable to improve the supply of the human or animal body with vitamin Bi 2 .
- sourgut according to at least one of the preceding numbers 21 to 23, characterized in that the sourgut has a mass fraction of vitamin Bi 2 , by at least 20%, preferably at least 30%, in particular at least 50%, compared to conventional, in particular with Lactobacillus amylovorus or Lactobacillus amylolyticus produced, acidity is increased.
- a high mass fraction of vitamin Bi 2 in the acidified product according to the invention means a significant increase in the vitamin Bi 2 content compared to conventional sauerkraut.
- the supply of the human or animal body can be further improved by an increased concentration of the vitamin Bi 2 in the sourgut.
- sourgut according to at least one of the preceding numbers 21 to 24, characterized in that the sourgut lactobacilli of the species Lactobacillus coryniformis, in particular the subspecies Lactobacillus coryniformis subsp. coryniformis (DSMZ No. 20007) or the species Lactobacillus backii (DSMZ No. 18080) or a mixture of lactic acid bacteria of these species.
- sourgut according to at least one of the preceding numbers 21 to 25, characterized in that the sourgut has a mass fraction of lactic acid in the range of about 0, 1 to 1, 0%, preferably 0.2 to 0.6%, preferably about 0, 3 to 0.5%, in particular about 0.35 to 0.45%.
- the second nutrient medium when performing step (p) has a temperature of at least 50 ° C, preferably at least 60 ° C, preferably at least 70 ° C, preferably at least 80 ° C, in particular at least 90 ° C, in particular at least 95 ° C, having.
- step (p) in a volume fraction of 2 to 20%, preferably from 5 to 15%, preferably 6 to 12%, preferably 7 to 1 1%, in particular 8 to 10%, based on the volume of the resulting mixture is added.
- an optimum pH for the mash or wort preferably a pH of the resulting mixture in the range of 4.2 to 5.5, preferably 4.6 to 5, 3, can be achieved.
- step (q) the mass fraction of water in the mash and / or wort to more than 0%, preferably more than 5%, is set.
- Mash preferably beer mash, or wort, preferably wort, in particular a AnstellTALze, prepared by a method according to any one of the preceding Nos. 30 to 34.
- a mash or wort produced according to the invention has an over conventional mash or seasoning increased content of vitamin Bi 2 , which is also bio available without being over acidified.
- mash according to the above number 40 characterized in that the mash has a pH in the range of 4.5 to 5.5, preferably 4.9 to 5.3 ,.
- Wort according to the above number 40 characterized in that the wort has a pH in the range of 4.2 to 5.4, preferably 4.6 to 5.0.
- the sourgut or the mash and / or wort produced according to the invention can be used in all ways known to the person skilled in the art for the production of a beverage.
- the acidification product according to the invention can be used for acidifying a mash and / or a seasoning.
- the mash according to the invention for producing a wort and the mash and / or wort produced according to the invention can be used to produce a beer, mixed beer beverage, non-alcoholic beer or for example fermented with a yeast or not fermented with yeast beverage of any kind. 51.
- the method according to the above number 50 characterized in that the method further comprises the step:
- step (a) the mass fraction of water in the beverage to more than 0%, preferably more than 5%, is set.
- a beverage preferably a non-alcoholic beverage or a beer, in particular a non-alcoholic beer, in particular a wheat beer, in particular a non-alcoholic wheat beer, prepared according to the method according to at least one of the preceding Nos. 50 to 52.
- beverage preferably a non-alcoholic beverage or a beer, in particular a non-alcoholic beer, in particular a wheat beer, in particular a non-alcoholic wheat beer, produced using lactic acid bacteria of the species Lactobaciüus coryniformis, in particular the subspecies Lactobaciüus coryniformis subsp. coryniformis (DSMZ No. 20007), or the species Lactobaciüus backii (DSMZ No. 18080) or a mixture of lactic acid bacteria of these species.
- Lactobaciüus coryniformis in particular the subspecies Lactobaciüus coryniformis subsp. coryniformis (DSMZ No. 20007), or the species Lactobaciüus backii (DSMZ No. 18080) or a mixture of lactic acid bacteria of these species.
- Drink preferably a non-alcoholic beverage or a beer, in particular a non-alcoholic beer, in particular a wheat beer, in particular a non-alcoholic wheat beer, produced using a sour material according to one of above numbers 20 to 26, a mash according to any of the preceding Nos. 40 to 42 and / or wort according to any of the preceding Nos. 40 to 42.
- beverage preferably a non-alcoholic beverage or a beer, in particular a non-alcoholic beer, in particular a wheat beer, in particular a non-alcoholic wheat beer, containing
- beverage according to at least one of the preceding numbers 60 to 63, characterized in that the beverage has a mass fraction of vitamin Bi 2 , by at least 20%, preferably at least 25%, preferably at least 30%, in particular at least 34%, compared to a analogously, in a conventional manner, in particular with Lactobacillus amylovorus or Lactobacillus amylolyticus, produced beverage is increased.
- the effect achieved according to the invention of the high bioavailability of the vitamin Bi 2 produced with the sourgut and its mass concentration in the further production process of the beverage in particular in the production of a beer, in particular of a non-alcoholic beer, remains intact.
- a Impairment of the bioavailability or a depletion in the further process steps up to the finished beverage does not take place according to the findings of the inventors or essentially does not take place.
- the same advantages of the sourdough produced according to the invention also apply analogously to the beverage produced according to the invention, in particular for the beer, in particular for the alcohol-free beer.
- (S) adjusting the mass fraction of water in the substrate to less than 35%, preferably less than 30%, preferably less than 25%, preferably less than 20%, in particular less than 15%.
- Method according to the above number 71 characterized in that the third nutrient medium has an extract content in the range of about 8 to 28%, preferably 10 to 22%, in particular 12 to 19, in particular 14 to 16%;
- step (t) The method according to the above number 71 or 72, characterized in that in step (t) the addition is carried out such that the substrate has a volume fraction of 2 to 8%, preferably 3 to 7%, in particular 3.5 to 6% to the volume of the mixture obtained in step (t).
- a mash and / or seasoning according to at least one of the preceding Nos. 40 to 42; or a mash and / or wort prepared according to a method according to at least one of the preceding Nos. 30 to 34;
- the mass fraction of water in the concentrate to less than 35%, preferably less than 30%, preferably less than 25%, preferably less than 20%, in particular less than 15%.
- a gel or paste-like consistency of the concentrate advantageously promotes a faster or better absorption of the nutrients contained therein, in particular of the vitamin Bi 2 , in the human or animal body.
- the concentrate according to the invention may have the above-defined mass ratio of glucose to fructose, whereby the physiological action is further improved.
- Concentrate according to at least one of the preceding Nos. 80 to 84 characterized in that the concentrate has a mass fraction of sodium ions in the range of 150 to 400 mg per portion, preferably 175 to 350 mg per portion, in particular 200 to 300 mg per portion of the concentrate wherein a portion of the concentrate has a mass in the range of 40 to 60 g.
- a mass fraction of sodium ions of less than 200, preferably less than 175, in particular less than 150 mg per serving optionally have insufficient physiological activity.
- a mass fraction of sodium ions of more than 300, preferably more than 350, in particular more than 400 mg per serving optionally has a laxative effect on the consumer.
- the concentrate described above has a reduced water content in relation to the sourgut produced according to the invention or a mash produced therewith. Due to the associated reduction in volume, transport and storage costs for the concentrate are reduced. Because of the higher osmotic pressure of the concentrate, its susceptibility to microbial infection is reduced, thereby increasing its storage stability.
- the concentrate can be made up everywhere and independently of the place of manufacture by re-dilution to the original concentration or a similar concentration.
- the concentrate has a higher viscosity compared to the starting material, which is advantageous in the use of the concentrate for the production of foodstuffs.
- the concentrate may serve as a binder for granular or powdered food ingredients. 90.
- a beverage preferably a soft drink, preferably a beer, preferably a non-alcoholic beer, in particular a wheat beer, in particular a non-alcoholic wheat beer.
- a process for producing a food preferably a cereal-containing food, in particular a cereal bar, a malt extract product or breakfast cereals, a baked good, or a dairy product, in particular yoghurt, wherein the food or one of its precursors a sourgut according to at least one of the preceding numbers 20 to 26, a mash according to at least one of the preceding Nos. 40 to 42, a wort according to at least one of the preceding Nos. 40 to 42, a beverage according to at least one of the preceding Nos.
- ⁇ -glucan causes, due to its property as a dietary fiber, an improvement in the physiological effects of the food according to the invention, in particular for the diet in a physically active way of life.
- Food preferably a cereal-containing foodstuff, in particular a cereal bar, a malt extract product or breakfast cereals, a baked good, or a dairy product, in particular yoghurt, prepared according to a method according to the above number 100 or 101.
- foodstuffs preferably a cereal-containing foodstuff, in particular a cereal-containing bar, a malt extract product or breakfast cereals, a baked good, or a milk product, in particular yoghurt; wherein the food contains vitamin Bi 2 ;
- the vitamin Bi 2 contained in the food contains a mass fraction of at least 80%, preferably at least 90%, preferably at least 95%, preferably at least 98%, preferably at least 99%, in particular 100% bioavailable, in particular bioavailable to the human or animal body , is.
- Foodstuff according to the above number 110 or 111 characterized in that the vitamin Bi 2 is selected from a group consisting of: methylcobalamin, deoxyadenosylcobalamin, hydroxocobalamin and sulfitcobalamin, in particular methylcobalamin and deoxyadenosylcobalamin.
- Foodstuffs according to at least one of the preceding numbers 1 10 to 1 13, characterized in that the food lactobacilli of the species Lactobaciüus coryniformis, in particular the subspecies Lactobaciüus coryniformis subsp. coryniformis (DSMZ No. 20007) or the species Lactobaciüus backii (DSMZ No. 18080) or a mixture of lactic acid bacteria of these species.
- Foodstuffs according to at least one of the preceding Nos. 1 10 to 1 16, characterized in that the food ß-glucan in a mass fraction of at least 0.8 g per portion, preferably at least 1, 0 g per portion, in particular at least 1, 2 g per portion of the food, wherein a portion of the food has a mass in the range of 40 to 60 g.
- Rösgebot corresponds or was made exclusively from ingredients, which are admitted after the German purity requirement for the production of beer. 1 19. Foodstuffs according to at least one of the preceding numbers 1 10 to 1 18, characterized in that the food has a gel or paste-like consistency.
- a gel or paste-like consistency of the food favorably promotes a faster or better absorption of the nutrients contained therein, in particular of the vitamin Bi 2 , in the human or animal body.
- Food or a concentrate can be provided, which is also characterized by an easy manageability or handling, for example during sports or leisure activities.
- Foodstuffs according to at least one of the preceding Nos. 1 10 to 1 19, characterized in that the foodstuff has a mass ratio of glucose to fructose in the range of 1.7: 1 to 2.3: 1, preferably 1: 8: 1 to 2 , 2: 1, preferably 1, 9: 1 to 2.1: 1, in particular about 2: 1, having.
- the food of the invention may be as defined above
- Mass ratio of glucose to fructose whereby the physiological effect is further improved.
- Foodstuffs according to at least one of the preceding numbers 1 10 to 120, characterized in that the foodstuff has a mass fraction of sodium ions of at least 50 mg per serving, preferably at least 75 mg per serving, preferably at least 100 mg per serving, preferably at least 125 mg per serving Portion, in particular at least 150 mg per portion of the food, wherein a portion of the food has a mass in the range of 40 to 60 g.
- the inventively provided mass fraction of sodium ions the physiological effect of the food, in particular the prevention or alleviation or prevention of muscle cramps, especially when using the food according to the invention as a sports food, further improved. Below the above-stated mass proportions of sodium ions, their physiological action is not sufficiently appreciated.
- lactic acid bacteria of the species Lactobacillus coryniformis in particular the subspecies Lactobacillus coryniformis subsp. coryniformis (DSMZ No. 20007), or the species Lactobacillus backii (DSMZ No. 18080) or a mixture of lactic acid bacteria of these species for the production of a sour good, a mash, a wort, a drink, preferably a beer, in particular a non-alcoholic beer, in particular a wheat beer, in particular a non-alcoholic wheat beer; or a concentrate, a food, a malt or a soft water.
- a foodstuff preferably a cereal-containing foodstuff, in particular a cereal bar or breakfast cereals, a baked good, or a milk product, in particular yoghurt, or a drink, preferably a non-alcoholic beverage, a beer-containing beverage or a beer, in particular a non-alcoholic beer, in particular a wheat beer, in particular a non-alcoholic wheat beer.
- the raw materials of the food or beverage according to the invention may be limited to the raw materials permitted for brewing beer, in particular barley malt, wheat malt and brewing water, and the microorganisms used according to the German Rösgebot.
- the food produced according to the invention also corresponds at least analogously to the German Purity Law.
- the food produced according to the invention is not limited to the above-mentioned foods, but by using the acidification according to the invention, mash, wort or concentrate, the benefits achieved according to the invention can be transferred to a variety of foods.
- Process for the preparation of a malt at least comprising the steps of: providing a maltable or malted raw material, preferably a maltable or malted cereal, in particular an unmalted or malted barley or an unmalted or malted wheat;
- lactobacilli of the species Lactobacillus coryniformis in particular the subspecies Lactobacillus coryniformis subsp. coryniformis (DSMZ No. 20007), or the species Lactobacillus backii (DSMZ No. 18080) or with a mixture of lactic acid bacteria of these species.
- Providing a suitable water for use in a malting process preferably a soft water; and (Y) treating the water with lactic acid bacteria of the species Lactobacillus coryniformis, in particular the subspecies Lactobacillus coryniformis subsp. coryniformis (DSMZ No. 20007), or the species Lactobacillus backii (DSMZ No. 18080) or with a mixture of lactic acid bacteria of these species.
- lactic acid bacteria of the species Lactobacillus coryniformis in particular the subspecies Lactobacillus coryniformis subsp. coryniformis (DSMZ No. 20007), or the species Lactobacillus backii (DSMZ No. 18080) or a mixture of lactic acid bacteria of these species for the treatment of a cereal, in particular an unmalted or malted cereal, or for the production of a soft water, in particular for the production of a beer brewing suitable malt.
- the treatment of the diluted wort with the inoculum, ie with the lactic acid bacteria takes place at a temperature of 15 to 43 ° C, in particular at about 37 ° C.
- the duration of treatment may be 10 to 48 hours, especially about 40 hours.
- the lactic acid bacteria metabolise components of the nutrient medium, ie the diluted wort, and produce besides vitamin L and other metabolic products also vitamin Bi 2 .
- the sourdough according to the invention now obtained has a lactic acid content of 0.2 to 0.6% by mass, in particular about 0.4% by mass.
- This freshly produced sourgut is then added to the wort acidification in a boiling rash wort until a predetermined target pH, for example 4.8, is reached.
- the addition of acidity to the wort takes place in about an amount of about 8 to 10% by volume of acidity, based on the resulting mixture of rash and sourdough.
- the resulting mixture is an edible wort which is acidified according to the invention. This can be used for beer production according to a conventional method, for example for the production of a non-alcoholic beer.
- Lactobacillus coryniformis is facultatively heterofermentative, in this species due to the reduced lactate production about twice the amount of sourgoods is required, namely about 8 to 10% by volume.
- the wort is gassed with the addition of the sourgut with C0 2 .
- a beer or a non-alcoholic beer can be produced from the setting wort produced according to the invention by the conventional methods.
- Comparative Example 1 represents an acidified product produced in a conventional manner.
- the process for producing this conventional acidulous product is identical to the process described above except for the following points:
- the inoculum or inoculum contains instead of Lactobacillus coryniformis subsp. coryniformis Lactobacillus amylovorus.
- the lactic acid content of the inoculum is about 0.3% by mass.
- the treatment of the diluted wort with the lactic acid bacteria prepared in the same manner as described above takes place at 48 ° C for 24 hours.
- the resulting acidity has a lactic acid content of 0.8% by mass.
- FIG. 1 The chromatogram shown in FIG. 1 represents the results of a bioavailability study according to Tanioka et al. Tanioka Y. et al: Analysis of Vitamin Bi 2 in Food by Silica Gel 60 TLC and Bioautography with Vitamin Bi 2 Dependent Escherichia coli 215, Journal of Liquid Chromatography and Related Technologies, vol. No. 13, 2008, pages 1977 to 1985). The associated details for the extraction and purification of the analyte are given in FIG.
- trace “B 12 " indicates bioavailable, synthetically produced vitamin Bi2 as reference (Rf value: 0.6) .
- the trace labeled “pseudo-Bi 2 " shows vitamin Bi 2 which is not bioavailable and an Rf value of 0.5 and 0.51, respectively, as a reference.
- the marks labeled “S4", “S5" and “S6” represent the results for a conventional beer (S4) and two non-leavened comparative sausages (S5, S6) prepared by the conventional method as described above in Comparative Example 1 , have been produced.
- the lane designated "S7" represents an acidity produced according to the invention with Lactobacillus coryniformis subsp. Coryniformis according to Example 1 above.
- the lane marked “S9” represents a conventional sourgrowth in which a seasoning has been treated by means of the lactic acid bacterium Lactobacillus amylovorus according to the above Comparative Example 1. As can be seen from the chromatogram, in the lanes
- the sourgut produced according to the invention (lane “S7") has a single signal at an Rf value of 0.6, which with the signal of the bioavailable Vitamin Bi is identical 2 (lane “B12"). From this it can be deduced that the at according to the invention produced Sauergut vitamin B 2 in a detectable amount. Further, it can be concluded that the presence of vitamin Bi 2 practically exclusively bio available vitamin Bi 2 ,
- a highly significant increase of the vitamin B i 2 content in the resulting wort can be set.
- the technological goal of pH adjustment is on For example, 4.8 achieved in the same manner as in a conventional Sauer good use.
- Lactobacillus coryniformis subsp. coryniformis produced sourgut at the Production of a beer also increased vitamin Bi2 levels in the resulting beer.
- the vitamin Bi2 content in an acidity is reduced by using Lactobacillus coryniformis subsp.
- Coryniformis compared to the conventional Lactobacillus amylovorus can be significantly increased.
- the inventors have found that the use of the acidification acid according to the invention for the acidification of a wort to a significant enrichment of vitamin Bi 2 in the resulting wort, such as a AnstellBruze leads.
- the setting wort according to the invention is further processed to a beer, for example a non-alcoholic beer, by a known method, an increase in the vitamin Bi 2 content in the finished beer can be achieved by about 34% according to the above example.
- the investigations of the inventors have shown that the vitamin Bi 2 contained in the abovementioned acidification product according to the invention, the acidified wort or seasoning wort and the beer or beverage according to the invention is completely or at least substantially completely bio available according to the above-mentioned definition , Production of an acid concentrate
- the acidity of the invention or else a wort or mash prepared therewith can be used for the preparation of a corresponding concentrate.
- the water content of the sourgut, the wort or the mash can be reduced by conventional methods, preferably the vacuum evaporation, to a desired consistency.
- Such a concentrate has the advantage of being less mass to be stored or transported.
- the microbiological stability of the concentrate according to the invention over the non-concentrated starting liquid, such as the acidification product according to the invention, the mash or wort according to the invention increased.
- it is further provided to produce a concentrate from the sourgut as well as from an acid-wort-wort mixture, in particular from a sour-sour wort mixture.
- the wort used for the acidification of the concentrate may be unhopped. Furthermore, this wort may have an extract content in the range of 14.5 to 16%.
- Example 2 Sourgut and Concentrate Therefrom About 215 liters of an initial wort with an extract content of 14.5 to 16% were inoculated with about 9.5 liters of the acidified product according to the invention, which was prepared according to example 1. After a treatment time of 42.7 hours at 37.5 ° C, the acidification product according to the invention was obtained. During the treatment, the headspace of the tank was filled with C0 2 . The resulting acidification product according to the invention was pasteurized at a wall temperature of 85.degree. The medium temperature was over 80 ° C for 27 minutes, maximum 81, 7 ° C. During the subsequent evaporation, a starting weight of 226.6 kg was assumed.
- the starting density at 71 ° C was 1,040.2 g / liter.
- the wall temperature was 85 ° C
- the medium temperature 71 ° C was 23 kg / hour.
- 65 kg of concentrate and 156.4 kg of condensate were obtained.
- the density of the concentrate obtained was 1177.8 g / liter at 71 ° C.
- the concentrate according to the invention (referred to in the following description to Fig. 3 as "S2") thus has only about 28.7% of the mass compared to the starting Sauer well.
- the concentrate according to the invention Due to the high extract content of the acidity or wort concentrate according to the invention, this has a sticky consistency. Due to its adhesive properties, the concentrate according to the invention is thus suitable as a natural "binder" for the production of, for example, cereal bars.
- FIG. 3 represents the results of a bioavailability study according to Tanioka et al. Tanioka Y. et al: Analysis of Vitamin Bi 2 in Food by Silica Gel 60 TLC and Bioautography with Vitamin Bi 2 Dependent Escherichia coli 215, Journal of Liquid Chromatography and Related Technologies, vol. No. 13, 2008, pages 1977 to 1985).
- the associated details for the extraction and purification of the analyte are given in FIG. In Fig. 3, the track "B 12 " shows bioavailable, synthetically produced vitamin
- the acidity concentrate produced according to the invention (lane “S2”) has as its sole signal one at an Rf value of 0.6, which is identical to the signal of the bioavailable vitamin Bi 2 (lane “B 12 "). From this it can be deduced that the concentrate according to the invention has produced vitamin B 2 in a detectable amount. In particular, it can be concluded that the existing vitamin Bi 2 is present almost exclusively as bioavailable vitamin Bi 2 .
- the soft water with a Lactobaciüus coryniformis subsp. Coryniformis containing inoculum are sprayed over.
- This treatment according to the invention preferably takes place at 37 ° C. for 48 hours.
- a sourmeal with a lactic acid content of 2 to 4% and increased levels of bioavailable vitamin Bi 2 is achieved.
- the aforementioned inoculum can be produced using wort or MRS medium.
- a nutrient medium in particular an MRS nutrient medium, was inoculated with lactic acid bacteria (Lactobacillus coryniformis subsp. Coryniformis) and incubated at 37 ° C for about 40 hours to recover an inoculated nutrient medium (inoculum).
- lactic acid bacteria Lactobacillus coryniformis subsp. Coryniformis
- the inoculated nutrient medium obtained as described above was used for inoculating a first wort diluted with brewing water in a volume ratio of 1: 1 and incubated at 37 ° C for about 40 hours to produce an acidified product of the present invention.
- sample recovery a sample of the sourgut was centrifuged under the same conditions and, analogously to the above samples 1 and 2, total vitamin Bi 2 as well as lactate in the supernatant (sample 3, see Table 3) and in the resuspended pellet after its Ultrasound treatment determined (sample 4, see Table 3).
- the total vitamin Bi2 concentration was determined by the method r-Biopharm AOAC method no. 101002.
- the lactic acid content was analyzed by HPLC, since the usual lactate
- Measuring devices measure only the L-lactate and not the enantiomeric form D-lactate.
- the lactic acid bacteria form both lactate forms, which can be measured by HPLC.
- the samples were first incubated for 60 seconds in an ultrasonic bath in order to destroy the cell structures (especially in the pellet). Subsequently, the suspension thus obtained was filtered through a tip filter (0.45 ⁇ ) and then diluted in a volume ratio of 1: 3 (v / v).
- the soft water produced by using Lactobacillus coryniformis of Example 5 according to the present invention contains a significantly increased amount of Vitamin Bi 2 .
- Granola bars are conventionally made from driers such as cereal products and a binder.
- a carbohydrate-based muesli bar is to be produced which consists essentially or exclusively of the ingredients used for the production of beer and / or its precursors or intermediates and is particularly suitable for athletes. Possibly sugar or a mixture of sugars may be added to the muesli bar.
- the general production process which can in principle also be based on the preparation of the cereal bar according to the invention, reference is made to the process described in US Pat. No. 4,451,488.
- An acidified product according to the invention produced according to Example 1 described above is concentrated, for example, in the manner described in Example 2.
- a conventionally prepared wort is concentrated in the manner described in Example 2. Both concentrates can be used as such or together with a sugar solution as a binder for the granola bars.
- dry ingredients for the cereal bar of the present invention may be any of the known cereal products, for example, wheat and / or barley based (e.g., wheat flakes or wheat crispies), especially as useful as beer-making ingredients. These are each mixed with one of the above-described concentrates as a binder and wheat germ oil (or other oil suitable as a food).
- the mass ratio of dry ingredients to binder is approximately in a range of 55:45 to 65:35.
- the resulting mixture is rolled out after homogenization in large sheets to a carpet and then dried in a drying oven, for example, for 10 to 30 minutes at 60 to 130 ° C. During the oven passage, the moisture is removed from the binder to the extent that the ingredients adhere to each other and thus can be cut to the desired size and shape.
- the binder is liquid at elevated temperatures and thus can be blended with the dry ingredients in a conventional homogenizer. After drying in the oven, a suitable binder is typically below about 40 ° C to prevent melting of the binder when holding the cereal bar in the hand of the consumer, storing at room temperature, or during transport.
- a concentrate of sour material according to the invention as it can be produced for example according to the above-mentioned Example 2, as a binder in a food such as a cereal bar, it is possible to introduce bio available vitamin B 2 in significant quantities in the food.
- the invention is not limited to the use of Lactobacillus coryniformis, in particular Lactobacillus coryniformis subsp. coryniformis, limited.
- the production methods and products described above can also be used or used with lactobacillus backu acid bacteria.
- the advantages and properties described above are realized in an analogous manner.
- the types Lactobaciüus amylovorus or Lactobaciüus amylolyticus are used for the mash and wort acidification, which have proven to be suitable for the production of corresponding sourdoughs and thus acidified mashes and seasonings for many years.
- these types of lactic acid are characterized by a growth dominance in wort for fast growing. Furthermore, they have a high pressure drop through high lactate production. This is due to their homofermentative metabolic character. These species grow at high temperatures (up to 52 ° C), so that high propagation rates can be achieved.
- these species can ferment dextrin and starch. Furthermore, they produce a high proportion of L (+) - lactate. Of considerable importance is that the said lactic acid bacteria are not harmful to beer, as they are hops sensitive and can not grow at temperatures ⁇ 30 ° C. Lactobacillus amylovorus and Lactobacillus amylolyticus are also considered suitable acidulants in the art because they do not form amines (histamine) or other toxins. In addition, they do not form diacetyl or other substances which are detrimental to the taste and aroma of the resulting products. Finally, they are characterized by easy handling in practical use.
- Lactobaciüus coryniformis in the art as a beer pest.
- This species grows in poorly hopped beer and produces diacetyl, which leads to an adverse taste profile in the resulting food or drink, especially in beer.
- Lactobaciüus coryniformis is able to grow at the typical fermentation temperatures for beer, especially for top-fermented beer, namely in the temperature range of 15 to 48 ° C.
- Lactobaciüus coryniformis has the disadvantage over the conventional species Lactobacillus amylovorus and Lactobacillus amylolyticus that this species is optionally heterofermentative, ie, its acidification capacity is reduced compared to the conventionally used species. Consequently, in about twice the amount of sourgut compared to conventional Species are used. This will require larger production facilities and increase the costs associated with acidification.
- Lactobacillus coryniformis and Lactobacillus backii represent a major obstacle to the use of these species or associated subspecies in the beverage and food manufacturing industry, especially in breweries and malting plants.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102013008335.4A DE102013008335A1 (de) | 2013-01-29 | 2013-01-29 | Verfahren zur Herstellung eines Nahrungsmittels sowie das damit hergestellte Nahrungsmittel und Verwendung von Milchsäurebakterien, eines Sauerguts, einer Maische, einer Würze, eines Getränks oder eines Konzentrats |
PCT/EP2014/051648 WO2014118191A1 (de) | 2013-01-29 | 2014-01-28 | Verfahren zur herstellung eines nahrungsmittels sowie das damit hergestellte nahrungsmittel und verwendung von milchsäurebakterien, eines sauerguts, einer maische, einer würze, eines getränks oder eines konzentrats |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2950664A1 true EP2950664A1 (de) | 2015-12-09 |
Family
ID=50033508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14702518.3A Withdrawn EP2950664A1 (de) | 2013-01-29 | 2014-01-28 | Verfahren zur herstellung eines nahrungsmittels sowie das damit hergestellte nahrungsmittel und verwendung von milchsäurebakterien, eines sauerguts, einer maische, einer würze, eines getränks oder eines konzentrats |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2950664A1 (de) |
DE (1) | DE102013008335A1 (de) |
WO (1) | WO2014118191A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102014110182A1 (de) * | 2014-07-18 | 2016-01-21 | Erdinger Weißbräu Werner Brombach GmbH & Co. KG | Verfahren zur Herstellung eines Nahrungsmittels oder einer Vorstufe desselben, Nahrungsmittel oder eine Vorstufe desselben und entsprechende Verwendung |
DE102017120283A1 (de) | 2017-09-04 | 2019-03-07 | Erdinger Weißbräu Werner Brombach GmbH & Co. KG | Verfahren zur Herstellung eines Nahrungsmittels oder einer Vorstufe desselben, Nahrungsmittel oder eine Vorstufe desselben und eine entsprechende Verwendung |
EP4051773A1 (de) * | 2019-10-30 | 2022-09-07 | Cargill, Incorporated | Malzextrakte mit heller farbe |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB793467A (en) | 1954-07-27 | 1958-04-16 | Pacific Yeast Products Inc | Production of vitamin b-12 products |
GB925526A (en) | 1960-05-12 | 1963-05-08 | Pierrel Spa | Method of preparing true vitamin b or cyanocobalamin by fermentation process |
GB1007972A (en) | 1960-12-23 | 1965-10-22 | Pierrel Spa | Biochemical process for the preparation of cyanocobalamin |
US4451488A (en) | 1981-06-22 | 1984-05-29 | The Quaker Oats Company | Food bar |
JPS58146292A (ja) | 1982-02-26 | 1983-08-31 | Nippon Oil Co Ltd | 醗酵法ビタミンb↓1↓2の製造方法 |
DE4138808C1 (de) | 1991-11-26 | 1993-04-01 | Feldschloesschen Brauerei Gmbh, 4236 Hamminkeln, De | |
AR022986A1 (es) | 1996-08-12 | 2002-09-04 | Gist Brocades Bv | Produccion y uso de composiciones que comprenden concentraciones altas de actividad de vitamina b12 |
WO1998057550A1 (en) * | 1997-06-19 | 1998-12-23 | Viva America Marketing, Inc. | Instant yogurt preparation |
JP2002540760A (ja) | 1998-12-18 | 2002-12-03 | デーエスエム・ナムローゼ・フェンノートシャップ | ビタミンb12の改良製造法 |
JP4336930B2 (ja) * | 2000-12-15 | 2009-09-30 | サンスター株式会社 | 乳酸菌発酵液の製造方法及び該発酵液を原料とする食品 |
CN1711036A (zh) | 2002-11-14 | 2005-12-21 | 帝斯曼知识产权资产管理有限公司 | 包括维生素b12的配方,生产方法及其用途 |
ES2561584T3 (es) * | 2005-09-28 | 2016-02-29 | Nordisk Rebalance A/S | Tratamiento del SII usando como efectores de tratamiento tanto bacterias probióticas como cereales fermentados |
DE102008018608A1 (de) | 2008-04-11 | 2009-10-15 | Versuchs- und Lehranstalt für Brauerei in Berlin (VLB) e.V. | Erfrischungsgetränk |
US8445226B2 (en) * | 2010-02-01 | 2013-05-21 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
US20140037798A1 (en) | 2011-02-09 | 2014-02-06 | Abbott Laboratories | Liquid nutritional products comprising metal amino acid chelates |
CN103491803A (zh) | 2011-04-21 | 2014-01-01 | 雀巢产品技术援助有限公司 | 具有固体颗粒的营养组合物及制备和使用它们的方法 |
-
2013
- 2013-01-29 DE DE102013008335.4A patent/DE102013008335A1/de not_active Ceased
-
2014
- 2014-01-28 EP EP14702518.3A patent/EP2950664A1/de not_active Withdrawn
- 2014-01-28 WO PCT/EP2014/051648 patent/WO2014118191A1/de active Application Filing
Non-Patent Citations (2)
Title |
---|
None * |
See also references of WO2014118191A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2014118191A1 (de) | 2014-08-07 |
DE102013008335A1 (de) | 2014-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69621121T2 (de) | Yoghurt | |
EP1042449B1 (de) | Mikroorganismus, verfahren zur gewinnung desselben sowie futtermittelzusatz | |
EP2950668A1 (de) | Verfahren zur herstellung eines sauergutes, sauergut, verfahren zur herstellung einer maische oder würze, maische oder würze, verfahren zur herstellung eines getränks, getränk, verfahren zur herstellung eines konzentrats, konzentrat | |
EP3598901A1 (de) | Beta-galactosidase aus l. bulgaricus zur synthese von galactooligosacchariden in molke | |
DE2952059C2 (de) | ||
EP2950664A1 (de) | Verfahren zur herstellung eines nahrungsmittels sowie das damit hergestellte nahrungsmittel und verwendung von milchsäurebakterien, eines sauerguts, einer maische, einer würze, eines getränks oder eines konzentrats | |
DE69616542T2 (de) | Beimpfen mit geotrichum candidum beim mälzen von zerealem korngut oder anderen pflanzen | |
EP0199105A1 (de) | Alkoholfreie Getränke auf Basis von Cerealien, Verfahren und Mikroorganismen zu ihrer Herstellung | |
EP1867728B1 (de) | Verfahren zur Herstellung einer mit B Vitaminen angereicherten Pflanze | |
EP0554488B1 (de) | Verfahren zur selektiven Verminderung des Zuckergehalts von zuckerhaltigen Nahrungsmitteln unter Beibehaltung der originären sensorischen Eigenschaften und danach erhaltene Nahrungsmittel | |
EP2995204B1 (de) | Verfahren zur herstellung eines nahrungsmittels oder einer vorstufe desselben, nahrungsmittel oder eine vorstufe desselben und entsprechende verwendungen | |
EP2412251B1 (de) | Verfahren zur Herstellung eines alkoholfreien Erfrischungsgetränks | |
DD150426A5 (de) | Verfahren zur herstellung von aminarmen nahrungsmitteln,genussmitteln und futtermitteln | |
EP3020285B1 (de) | Zusammensetzung umfassend sauergut, cerealienmehl und hopfen | |
EP3450534A1 (de) | Verfahren zur herstellung eines nahrungsmittels oder einer vorstufe desselben, nahrungsmittel oder eine vorstufe desselben und eine entsprechende verwendung | |
DE102013008336A1 (de) | Verfahren zur Herstellung eines Malzes sowie damit hergestelltes Malz, Verfahren zur Herstellung eines Weichwassers sowie damit hergestelltes Weichwasser; Verwendung von Milchsäurebakterien | |
DE102010036921A1 (de) | Verfahren zur Herstellung eines Getränks und Getränk | |
DE202021101792U1 (de) | Fermentierter Extrakt und ein Lebensmittelprodukt, das diesen Extrakt enthält | |
KR20150138952A (ko) | 저알코올 음료의 제조 방법 | |
KR20160009800A (ko) | 보리 유산균 발효물, 보리발효음료 및 그의 제조방법 | |
DE10257385B4 (de) | Getränkegrundstoffe, deren Zwischenprodukte, daraus resultierende Getränke und ein Verfahren zu deren Herstellung | |
DE102004045500A1 (de) | Verfahren zur Herstellung eines Getränks | |
DE19932055B4 (de) | Milchsäure, lebensfähige Milchsäurebakterien und Hefen enthaltende Flüssigkeit sowie Verfahren zu deren Herstellung | |
EP2024489B1 (de) | Verfahren zur produktion von hefe | |
DE102005001587A1 (de) | Biomasse von Wildtypmikroorganismen als Nahrungsergänzungsmitteln |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20150818 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ERDINGER WEISSBRAEU WERNER BROMBACH GMBH & CO. KG |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20170509 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: PIECZONKA, KLAUS Inventor name: FISCHER, MALAIKA Inventor name: LIEBERT, PETER |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20171117 |